Redeye reiterates its positive view of the stock, on the back of a solid Q3 report with a rolling 12-month order intake of 909m, and the big school zones opportunity. We raise our valuation.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases